Treatment of metastatic malignant melanoma
- 1 May 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Treatment Options in Oncology
- Vol. 6 (3), 185-193
- https://doi.org/10.1007/s11864-005-0002-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytesProceedings of the National Academy of Sciences of the United States of America, 2004
- The role of taxanes in the treatment of metastatic melanomaMelanoma Research, 2004
- Isolated limb infusion for melanoma: A simple but effective alternative to isolated limb perfusionJournal of Surgical Oncology, 2004
- Management of Cutaneous MelanomaNew England Journal of Medicine, 2004
- Management of brain metastases in patients with melanomaCurrent Opinion in Oncology, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Phase II randomized trial of cisplatin and WR-2721 versus cisplatin alone for metastatic melanomaMelanoma Research, 2003
- Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic MelanomaJournal of Clinical Oncology, 2003
- Metastatic melanoma: ChemotherapySeminars in Oncology, 2002
- Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-upMelanoma Research, 1995